Volume 5 Supplement 2
Anxiety, depression and hyperventilation symptoms in treatment-resistant severe asthma
© Li Leng karen et al; licensee BioMed Central Ltd. 2015
Published: 23 March 2015
Psychological morbidity is associated with frequent asthma exacerbations, higher health care utilization, as well as near-fatal and fatal asthma. The prevalence of psychological comorbidities in patients with severe asthma is not well-studied. The aim of our study was to evaluate the prevalence of anxiety, depression and hyperventilation, and correlate these symptoms with asthma control, exacerbation frequency and lung function in severe asthmatics.
Patients who fulfilled the WHO definition of "treatment-resistant severe asthma" (at least combination high-dose inhaled corticosteroids and long-acting beta agonists) were included. Patients literate in English completed the Hospital Anxiety and Depression Scale (HADS) and Nijmegen Questionnaire during a regular doctor's visit at our Severe Asthma clinic. The HADS questionnaire comprises 7 anxiety and 7 depression questions. A cut-off score of ≥8 indicates a probable case of anxiety or depression. Nijmegen Questionnaire is a screening instrument for hyperventilation. A score of ≥23 suggests hyperventilation. Relation between these scores and Asthma Control Test, exacerbation frequency, health care utilization and lung function test results were analyzed.
52 patients were included in the analysis: 24 (46.2%) male, mean age 37.5 ±16.6 years, mean ACT score 16.8 ±4.5. The prevalence of anxiety was 44.2%, depression was 19.2% and hyperventilation was 28.8%. Patients with anxiety were more likely to have uncontrolled asthma (defined as Asthma Control Test score of 19 or less) compared to those without (87.0% vs. 51.7%, p=0.009). Similarly, patients with hyperventilation were more likely to have uncontrolled asthma compared to those without (93.3% vs. 56.8%, p=0.011). There was no association between depression and asthma control. Patients with anxiety had lower FEV1 % predicted compared to those without (69.4±17.2% vs. 81.2±21.2%, p=0.036). There was no association between depression or hyperventilation and FEV1. No association was found between anxiety, depression or hyperventilation and frequency of asthma exacerbations.
A high prevalence of anxiety, hyperventilation and depression exists amongst our severe asthmatics. Hyperventilation and anxiety were associated with uncontrolled asthma, and presence of anxiety was associated with a lower FEV1 % predicted. This suggests that there is an objective association between anxiety and uncontrolled asthma, although the causal link remains unclear.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.